npj Genomic Medicine

SJR Rank #1,127H-index: 50SJR: 2.273Best quartile: Q1Open AccessAPC: US$4,190Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Nature Research

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.61.21.82.4

Subject Categories

  • GeneticsQ1
  • Genetics (clinical)Q1
  • Molecular BiologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Genomics and Rare DiseasesGenomic variations and chromosomal abnormalitiesCancer Genomics and DiagnosticsGenetic Associations and EpidemiologyGenetics and Neurodevelopmental DisordersGenetic factors in colorectal cancerRNA modifications and cancerBRCA gene mutations in cancerEpigenetics and DNA MethylationPrenatal Screening and Diagnostics

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs050100150200

Documents per Year

20222025020406080

Detailed Information

ISSN

2056-7944

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.91

References per Document

62.56

Coverage

2016-2026

Scope

npj Genomic Medicine is an international, peer-reviewed journal dedicated to publishing the most important scientific advances in all aspects of genomics and its application in the practice of medicine. The journal defines genomic medicine as "diagnosis, prognosis, prevention and/or treatment of disease and disorders of the mind and body, using approaches informed or enabled by knowledge of the genome and the molecules it encodes." Relevant and high-impact papers that encompass studies of individuals, families, or populations are considered for publication including (but not limited to): integrative phenotype and genome data and analysis, including immunogenomics, pharmacogenomics, microbiomics and system medicine, disease-specific polymorphisms, disease- and aging-related epigenetics and epigenomics, germline and de novo mutations, including point mutations, indels and copy-number alterations, data mining and artificial intelligence, disease-related alterations to the 3D genome, new technologies and informatics, clinical recommendations and/or guidelines of how that data should be used in the clinical management of patients, clinical studies of utility and outcomes in patients receiving genomic medicine, learning healthcare systems related to genomic medicine.

Metrics from SCImago Journal Rank 2025. View on SCImago